Light Mode
$0.1301 ↑ +0.0162 (+14.18%) Trading Up from the previous close of $0.1140, and at the day’s high of $0.1301
-0.02 (-13.27%) / 6M
Momentum, market sentiment, and recent alerts
CASIF reads very good: the 12-month move is -43.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market. The company was founded in 1991 and is headquartered in Beijing, China.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.